Gut Microbiota in Inflammation and Colorectal Cancer: A Potential Toolbox For Clinicians
N Grellier, A Severino, S Archilei, J Kim… - Best Practice & …, 2024 - Elsevier
Colorectal cancer (CRC) is a worldwide public health issue specifically in patients with
chronic diseases associated with a western lifestyle, such as metabolic diseases and …
chronic diseases associated with a western lifestyle, such as metabolic diseases and …
[HTML][HTML] Gut microbiota in colorectal cancer: from pathogenesis to clinic
W Fusco, L Bricca, F Kaitsas, MF Tartaglia… - Best Practice & …, 2024 - Elsevier
Colorectal cancer is the third most common type of cancer, with a significant burden on
healthcare and social systems. Its incidence is constantly rising, due to the spread of …
healthcare and social systems. Its incidence is constantly rising, due to the spread of …
Combining methylated SDC2 test in stool DNA, fecal immunochemical test, and tumor markers improves early detection of colorectal neoplasms
T Zeng, Z Huang, X Yu, L Zheng, T Liu, B Tian… - Frontiers in …, 2023 - frontiersin.org
Objective To explore the value of testing methylated SDC2 (SDC2) in stool DNA combined
with fecal immunochemical test (FIT) and serum tumor markers (TM) for the early detection of …
with fecal immunochemical test (FIT) and serum tumor markers (TM) for the early detection of …
Performance of the Asia–Pacific Colorectal Screening score in stratifying the risk of advanced colorectal neoplasia: A meta‐analysis and systematic review
MN Luu, NA Trinh, TLT Tran, TP Dang… - Journal of …, 2024 - Wiley Online Library
Abstract Background and Aim This study systematically reviewed and meta‐analyzed the
performance of the Asia–Pacific Colorectal Screening (APCS) score and its incorporation …
performance of the Asia–Pacific Colorectal Screening (APCS) score and its incorporation …
[HTML][HTML] Colorectal cancer screening: A review of current knowledge and progress in research
SR Lopes, C Martins, IC Santos, M Teixeira… - World Journal of …, 2024 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is one of the most prevalent malignancies worldwide, being the
third most commonly diagnosed malignancy and the second leading cause of cancer …
third most commonly diagnosed malignancy and the second leading cause of cancer …
[HTML][HTML] Machine learning-based identification of colorectal advanced adenoma using clinical and laboratory data: a phase I exploratory study in accordance with …
H Wang, X Cao, P Meng, C Zheng, J Liu, Y Liu… - Frontiers in …, 2024 - frontiersin.org
Objective The recent World Endoscopy Organization (WEO) guidelines now recognize
precursor lesions of colorectal cancer (CRC) as legitimate screening targets. However, an …
precursor lesions of colorectal cancer (CRC) as legitimate screening targets. However, an …
Disease Burden of Colorectal Cancer in China from 1990 to 2019: Age-and Sex-Specific Time Trends and 10-Year Forecast
G Zhai, Y Wang - Oncology Research and Treatment, 2024 - karger.com
Introduction: Colorectal cancer (CRC) is the third most prevalent malignant tumor worldwide
and the second leading cause of cancer-related death. This study aimed at reporting the …
and the second leading cause of cancer-related death. This study aimed at reporting the …
Risk Classification After Colonoscopy and Polypectomy: Are We Always Fighting the Last War?
JE East - Gastroenterology, 2023 - gastrojournal.org
In the 1970s and 1980s postpolypectomy surveillance intervals of 1 year were common,
leading to a significant surveillance burden and diverting resources from screening and …
leading to a significant surveillance burden and diverting resources from screening and …